Search
Menu
Home
HTB
2023
April
April 2023
Contents
Editorial
HTB April 2023 (6 April 2023)
Conference reports
30th CROI (CROI 2023): further reports
Dapivirine ring safe in late pregnancy and during breastfeeding
Implications of restrictions on reproductive rights for HIV care in the USA and beyond
Antiretrovirals
Generic versions of injectable PrEP could enable access to CAB-LA in low-income countries
mpox
UK data on efficacy of mpox vaccine: caution needed in observational analyses
Updates on US mpox research: surveillance, testing, vaccines and research
Cases of mpox reinfection in HIV negative men on PrEP: atovaquone, mefloquine and molnupiravir as potential treatments
Coinfections and complications
Statins reduce heart disease by 35% in the international HIV REPRIEVE study
Penile BOTOX injections improve blood flow and other outcomes in men with moderate to severe erectile dysfunction
Cure-related research
HIV cures 3, 4 and 5: Düsseldorf case published, City of Hope patient gives public interview, New York case published
Drug resistance
IAS-USA update HIV drug resistance tables
Treatment advocacy
David Wojnarowicz: F**k You F*ggot F**ker – now online
On the web
Long-term survivors & HIV cure research
Training webinar: 2nd HIV from A to Z
PDFs
HTB: no. 4 (April 2023) PDF download
HTB RSS
Early access
HPW news: Closed clinics and limited ART in Zimbabwe
4 May 2025
The RIO study: Q&A about controlling HIV with bNAbs
21 April 2025
Lenacapavir EAP in the UK closed to new referrals: NHS England and Gilead fail to agree a price after more than two years
20 April 2025
Viral failure on CAB/RPV-LA: overcoming drug resistance with second-generation INSTIs
13 April 2025
All early access reports
Current issues
May 2025
April 2025
March 2025
Back issues
Special report
Lancet HIV recognises Transgender Day of Visibility and the importance of gender-affirming hormones in HIV care
3 April 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate